XML 27 R15.htm IDEA: XBRL DOCUMENT
v3.24.3

Earnings per Common Share | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
Earnings per Common Share | Earnings per Common Share The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 147.8 |  |  | $ | 114.7 |  |  | $ | 435.6 |  |  | $ | 347.4 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (38.9) |  |  | (28.1) |  |  | (97.6) |  |  | (79.5) |
Less: Income allocated to participating securities | (0.7) |  |  | (0.6) |  |  | (2.0) |  |  | (1.8) |
Income from continuing operations attributable to Encompass Health common shareholders | 108.2 |  |  | 86.0 |  |  | 336.0 |  |  | 266.1 |
Loss from discontinued operations attributable to Encompass Health common shareholders | (0.7) |  |  | (1.3) |  |  | (3.2) |  |  | (3.5) |
Net income attributable to Encompass Health common shareholders | $ | 107.5 |  |  | $ | 84.7 |  |  | $ | 332.8 |  |  | $ | 262.6 |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 99.9 |  |  | 99.5 |  |  | 99.9 |  |  | 99.5 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.09 |  |  | $ | 0.86 |  |  | $ | 3.36 |  |  | $ | 2.68 |
Discontinued operations | (0.01) |  |  | (0.01) |  |  | (0.03) |  |  | (0.04) |
Net income | $ | 1.08 |  |  | $ | 0.85 |  |  | $ | 3.33 |  |  | $ | 2.64 |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 147.8 |  |  | $ | 114.7 |  |  | $ | 435.6 |  |  | $ | 347.4 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (38.9) |  |  | (28.1) |  |  | (97.6) |  |  | (79.5) |
Income from continuing operations attributable to Encompass Health common shareholders | 108.9 |  |  | 86.6 |  |  | 338.0 |  |  | 267.9 |
Loss from discontinued operations attributable to Encompass Health common shareholders | (0.7) |  |  | (1.3) |  |  | (3.2) |  |  | (3.5) |
Net income attributable to Encompass Health common shareholders | $ | 108.2 |  |  | $ | 85.3 |  |  | $ | 334.8 |  |  | $ | 264.4 |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 102.1 |  |  | 101.4 |  |  | 102.2 |  |  | 101.1 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.07 |  |  | $ | 0.85 |  |  | $ | 3.31 |  |  | $ | 2.65 |
Discontinued operations | (0.01) |  |  | (0.01) |  |  | (0.03) |  |  | (0.03) |
Net income | $ | 1.06 |  |  | $ | 0.84 |  |  | $ | 3.28 |  |  | $ | 2.62 |
The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Basic weighted average common shares outstanding | 99.9 |  |  | 99.5 |  |  | 99.9 |  |  | 99.5 |
Restricted stock awards, dilutive stock options, and restricted stock units | 2.2 |  |  | 1.9 |  |  | 2.3 |  |  | 1.6 |
Diluted weighted average common shares outstanding | 102.1 |  |  | 101.4 |  |  | 102.2 |  |  | 101.1 |
See Note 17, Earnings per Common Share, to the consolidated financial statements accompanying the 2023 Form 10‑K for additional information related to our common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration